North Star Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

North Star Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,000	Closed	-$16.7K	–	922
2015 Q3	$20K	Buy	4,000 +1,100	+38%	+$6.3K	﹤0.01%	515
2015 Q2	$19K	Hold	2,900	–	–	﹤0.01%	501
2015 Q1	$20K	Hold	2,900	–	–	﹤0.01%	484
2014 Q4	$22K	Hold	2,900	–	–	﹤0.01%	473
2014 Q3	$22K	Hold	2,900	–	–	﹤0.01%	454
2014 Q2	$28K	Hold	2,900	–	–	0.01%	455
2014 Q1	$24K	Buy	+2,900	New	+$24.9K	0.01%	455

Other funds holding PDLI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

North Star Investment Management's PDLI Position: Q4 2015 in Review

North Star Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 4,000 shares — an estimated $16.7K sold.

North Star Investment Management first reported a position in PDLI in Q1 2014 and held it in 7 quarters. The position peaked at $28K in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

North Star Investment Management reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
North Star Investment Management sold 4,000 PDL BioPharma, Inc. shares in Q4 2015, an estimated $16.7K.
North Star Investment Management first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 7 quarters.
North Star Investment Management's PDL BioPharma, Inc. position peaked at $28K in Q2 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on North Star Investment Management's 13F filing for Q4 2015, filed 20 Jan 2016.